1. Home
  2. CRNX vs LRN Comparison

CRNX vs LRN Comparison

Compare CRNX & LRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Crinetics Pharmaceuticals Inc.

CRNX

Crinetics Pharmaceuticals Inc.

HOLD

Current Price

$40.24

Market Cap

3.9B

Sector

Health Care

ML Signal

HOLD

Logo Stride Inc.

LRN

Stride Inc.

HOLD

Current Price

$99.14

Market Cap

3.6B

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRNX
LRN
Founded
2008
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Other Consumer Services
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
3.9B
3.6B
IPO Year
2018
2007

Fundamental Metrics

Financial Performance
Metric
CRNX
LRN
Price
$40.24
$99.14
Analyst Decision
Strong Buy
Buy
Analyst Count
8
4
Target Price
$76.63
$106.75
AVG Volume (30 Days)
1.1M
573.0K
Earning Date
05-07-2026
04-28-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
26.87
EPS
N/A
3.49
Revenue
$1,039,000.00
$917,734,000.00
Revenue This Year
$720.10
$6.18
Revenue Next Year
$184.67
$4.74
P/E Ratio
N/A
$28.21
Revenue Growth
N/A
3.29
52 Week Low
$25.83
$60.61
52 Week High
$57.99
$171.17

Technical Indicators

Market Signals
Indicator
CRNX
LRN
Relative Strength Index (RSI) 56.29 77.71
Support Level $39.35 $81.27
Resistance Level $45.32 $148.37
Average True Range (ATR) 1.44 2.64
MACD 0.56 0.88
Stochastic Oscillator 83.70 93.44

Price Performance

Historical Comparison
CRNX
LRN

About CRNX Crinetics Pharmaceuticals Inc.

Crinetics Pharmaceuticals Inc is a commercial-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its main product, Palsonify (paltusotine), is a once-daily, oral treatment approved by the FDA for adults with acromegaly who have had an inadequate response to surgery and/or for whom surgery is not an option. Additionally, the company's development pipeline includes several programs, including a late-stage investigational candidate, atumelnant, currently in development for CAH and ADCS, and CRN09682, a NDC candidate that is being developed to treat SST2-expressing NETs and other SST2-expressing solid tumors.

About LRN Stride Inc.

Stride Inc is an American online educational company. It offers alternative programs to traditional on-campus schooling. It also operates state-funded virtual charter schools around the United States. The educational programs for K-12 students are usually monitored by parents and provide virtual classroom environments where teachers meet with students online, by phone, or in-person. The company's contractual agreements with various school districts to offer its curriculum programs provide a majority of the company's revenue. The company lines of business are Managed Public School Programs, Institutional and Private Pay Schools and Other.

Share on Social Networks: